Open AccessPost Hoc Analysis of Lorlatinib Intracranial Efficacy and Safety in Patients With ALK-Positive Advanced Non–Small-Cell Lung Cancer From the Phase III CROWN Study
Author(s) -
Benjamin Solomon,
Todd M. Bauer,
SaiHong Ignatius Ou,
Geoffrey Liu,
Hidetoshi Hayashi,
Alessandra Bearz,
Konstantin Penkov,
YiLong Wu,
Óscar Arrieta,
Jacek Jassem,
Anna Maria Calella,
Gerson Peltz,
Anna Polli,
Holger Thurm,
Tony Mok
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.21.02278
Subject(s) - medicine , crizotinib , post hoc analysis , lung cancer , adverse effect , incidence (geometry) , alk inhibitor , oncology , physics , optics , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom